Shasha Li
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Identification of Tumor Hypoxia-Activated Degradation-Targeting Chimeras.
Journal: Journal of medicinal chemistry
Published: February 21, 2026
Design, synthesis and biological evaluation of the tumor hypoxia-activated PROTACs bearing caged CRBN E3 ligase ligands.
Journal: Bioorganic & medicinal chemistry
Published: January 18, 2023
Chemoproteomics reveals arctigenin as a phagophore-closure blocker via targeting ESCRT-I subunit VPS28.
Journal: Bioorganic chemistry
Published: December 26, 2022
Circ_0073228 serves as a competitive endogenous ribonucleic acid to facilitate proliferation and inhibit apoptosis of hepatocellular carcinoma cells by the miR-139-5p/deoxyribonuclease II axis.
Journal: The journal of gene medicine
Published: November 23, 2022
Design, Synthesis, and Biological Evaluation of 2-Anilino-4-Triazolpyrimidine Derivatives as CDK4/HDACs Inhibitors.
Journal: Drug design, development and therapy
Published: December 01, 2021
Development of hypoxia-activated PROTAC exerting a more potent effect in tumor hypoxia than in normoxia.
Journal: Chemical communications (Cambridge, England)
Published: November 17, 2021
Construction and evaluation of a prognosis lncRNA model for hepatocellular carcinoma.
Journal: Journal of cellular biochemistry
Published: June 01, 2019
Tumor suppressive functions of LZTFL1 in hepatocellular carcinoma.
Journal: OncoTargets and therapy
Published: December 04, 2018
NH4Cl affects the expression of Wnt/β-catenin pathway in hepatocytes.
Journal: Canadian journal of physiology and pharmacology
Published: October 05, 2017
Showing 1-10 of 10
Last Updated: 09/26/2026